Patrick Brown
Medical Oncology · Baltimore, MDNPI 1154389633
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $47,815 of the $51,813 with a category attached, or 92.3%. 7 manufacturers reported payments, led by Amgen at 46.3% of the total. Reporting peaked in 2021 at $19,678 and has fallen 86.8% since, to $2,600 in 2023.
Across 38 payments — averaging $1363.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amgen$24K
- Novartis$12K
- Jazz Pharmaceuticals Inc.$7K
- Servier Pharmaceuticals LLC$4K
- Takeda Pharmaceuticals U.S.A., Inc.$3K
- Beigene, Ltd.$3K
- plus $88 from 1 others
Across 86 payments — averaging $76,176 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amgen$6.1M
- Novartis$219K
- Janssen Research & Development, LLC$125K
- Gilead$89K
- Incyte Corporation$28K
- E.r. Squibb & Sons, L.L.C.$430
- plus $704 from 2 others
What the payments were for
- Consulting fees$47,81592%
- Speaking & faculty fees$1,7383%
- Travel & lodging$1,7423%
- Food & beverage$5171%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amgen | 12 | $24,004 |
| Novartis | 12 | $11,792 |
| Jazz Pharmaceuticals Inc. | 3 | $6,930 |
| Servier Pharmaceuticals LLC | 7 | $3,759 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $2,640 |
| Beigene, Ltd. | 1 | $2,600 |
| AstraZeneca | 2 | $88 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$51,813 in reported general payments places this provider in the 80th percentile of 180 medical oncology providers in Maryland.
Other medical oncology in Baltimore
- Mario EisenbergerBaltimore$2.9M
- David SidranskyBaltimore$520K
- Carole MillerBaltimore$331K
- Mark LevisBaltimore$323K
- Tanguy Lim-SeiwertBaltimore$301K
- Shruti ChaturvediBaltimore$265K
- Sandy KotiahBaltimore$247K
- Bruce SmithBaltimore$235K
- Evan LipsonBaltimore$228K
- Nilofer AzadBaltimore$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.